教員業績データベース |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma |
掲載誌名 | 正式名:Liver international : official journal of the International Association for the Study of the Liver 略 称:Liver Int ISSNコード:14783223/14783231 |
掲載区分 | 国外 |
巻・号・頁 | 44(1),pp.113-124 |
著者・共著者 | Tada Toshifumi, Kumada Takashi, Hiraoka Atsushi, Kariyama Kazuya, Tani Joji, Atsukawa Masanori, Takaguchi Koichi, Itobayashi Ei, Fukunishi Shinya, Tsuji Kunihiro, Ishikawa Toru, Tajiri Kazuto, Ochi Hironori, Yasuda Satoshi, Toyoda Hidenori, Ogawa Chikara, Nishimura Takashi, Hatanaka Takeshi, Kakizaki Satoru, Shimada Noritomo, Kawata Kazuhito, Tada Fujimasa, Ohama Hideko, Nouso Kazuhiro, Morishita Asahiro, Tsutsui Akemi, Nagano Takuya, Itokawa Norio, Okubo Tomomi, Arai Taeang, Imai Michitaka, Kosaka Hisashi, Naganuma Atsushi, Matono Tomomitsu, Aoki Tomoko, Kuroda Hidekatsu, Yata Yutaka, Koizumi Yohei, Nakamura Shinichiro, Kaibori Masaki, Iijima Hiroko, Hiasa Yoichi, Kudo Masatoshi, Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group |
発行年月 | 2024/01 |